Non-alcoholic fatty liver disease (NAFLD) represents the most common liver disease worldwide affecting approximatively 20–30% ...

If tomorrow was your last day, what would you eat and what would you reflect on? Tom Nash talks about the live launch of his ...

Belfort et al. randomly assigned 55 patients with biopsy-confirmed NASH and either impaired glucose tolerance or type 2 diabetes to receive a hypocaloric diet plus either pioglitazone (30 mg daily ...

Currently, treatment options for NAFLD are limited; the main approaches focus on lifestyle modifications, particularly weight loss through diet and exercise, which are difficult for patients to ...